Citi Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $68.46 -2.53%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Citi initiates coverage on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a Buy. PT $45.00.
For an analyst ratings summary and ratings history on BioMarin Pharmaceutical Inc. click here. For more ratings news on BioMarin Pharmaceutical Inc. click here.
Shares of BioMarin Pharmaceutical Inc. closed at $35.26 yesterday.
For an analyst ratings summary and ratings history on BioMarin Pharmaceutical Inc. click here. For more ratings news on BioMarin Pharmaceutical Inc. click here.
Shares of BioMarin Pharmaceutical Inc. closed at $35.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Financial Stress Deepens Divide among U.S. Credit Card Customers, According to JD Power
- Citi Investor Services Wins US$380 Billion Middle Office Mandate from Aegon Asset Management
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
